Edmund Olivier

Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston.

The Company's principal activity is to acquire or merger a business combination with operations primarily in India. The Company is in its development stage.

Ceres, Inc. engages in the development and market of low-carbon and non-food grasses for advanced biofuels and biopower. The company was founded by Walter De Logi, Richard William Hamilton, and Robert B. Goldberg on October 28, 1996 and is headquartered in Arden Hills, MN.

Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom.

EGeen International Corp. provides drugs and medical services. It focuses on therapeutics, such as anti-inflammatory, anti-infectives, CVD, dermatology, metabolism and endocrine, CNS and neurology, oncology, pulmonary, and vaccines. The firm specializes in clinical trials of biologics, therapeutic vaccines, drug or device combinations, and various formulations of small molecule drugs. The company was founded by Kalev Kask in 2001 and is headquartered in Mountain View, CA.

Founded in 2001, Coastview Capital LLC is a venture capital firm headquartered in Los Angeles